Funded Tech Companies

Stargazer Pharmaceuticals

Wondering who invested in Stargazer Pharmaceuticals? Novo Ventures, venBio and Canaan Partners joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Stargazer Pharmaceuticals
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
200 Clarendon St. 45th Floor Mailbox 30
Boston, MA 02215
USA
Email Address
Not Recorded

Company Background Information

Overview
Stargazer Pharmaceuticals, Inc., is a Boston-based biopharmaceutical drug development company launched in 2018 with a focus on rare diseases of the eye, and an initial focus on Stargardt Disease.
Profile
Stargazer Pharmaceuticals LinkedIn Company Profile
Social Media
Stargazer Pharmaceuticals Company Twitter Account
Company News
Stargazer Pharmaceuticals News
Facebook
Stargazer Pharmaceuticals on Facebook
YouTube
Stargazer Pharmaceuticals on YouTube
Last Transaction
11/10/2020

Financing History

Date
Type
Amount
Venture Equity
$57,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Gary Sternberg
  Gary Sternberg LinkedIn Profile  Gary Sternberg Twitter Account  Gary Sternberg News  Gary Sternberg on Facebook
Chief Marketing Officer
Houman Hemmati
  Houman Hemmati LinkedIn Profile  Houman Hemmati Twitter Account  Houman Hemmati News  Houman Hemmati on Facebook
Chief Operating Officer
Silvia Ragno
  Silvia Ragno LinkedIn Profile  Silvia Ragno Twitter Account  Silvia Ragno News  Silvia Ragno on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Stargate Hydrogen | StarGen

 

Share this article

 


About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary